Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Australian News Journal.
Press releases published on February 24, 2026
Feb. 24, 2026
Employment Hero Named Among Best Australian & New Zealand Companies by G2
Indeterminate
EIN Presswire
Feb. 24, 2026
B2i Digital Highlights Hybrid Australia Investor Day as a Featured Conference
Indeterminate
EIN Presswire
Feb. 24, 2026
Microgravity Mission to Unlock New Insights into Cancer Biology
Indeterminate
EIN Presswire
Feb. 24, 2026
AstroDoc Introduces ASTRID, a Free AI-Powered Healthcare Companion Now Available Globally
Indeterminate
EIN Presswire
Feb. 24, 2026
Working With an Adelaide Marketing Consultant to Strengthen Brand Positioning
Indeterminate
EIN Presswire
Feb. 24, 2026
SageScreen™ Launches AI Interview Platform with Bias Mitigation, Fraud Detection and 20+ Languages
Indeterminate
EIN Presswire
Feb. 24, 2026
Elevra Lithium Limited (ELV.AX) FY26 Half Year Results Announcement
Indeterminate
ABN Newswire
Feb. 24, 2026
Toronto to Host Global Mineral Sector for PDAC 2026, March 1-4
Indeterminate
ABN Newswire
Feb. 24, 2026
Pull Up Banner Design and Print Supporting Adelaide’s Growing Event and Retail Sectors
Indeterminate
EIN Presswire
Feb. 24, 2026
Catalina Resources Ltd (CTN.AX) Advances Flamingo Cu Au Exploration Model
Indeterminate
ABN Newswire
Feb. 24, 2026
Castles Technology Selects Bright Pattern to Modernize Global Customer Support
Indeterminate
EIN Presswire
Feb. 24, 2026
Bali Belly Cases Rise in Rainy Season, Doctors Warn Australian Travellers
Indeterminate
EIN Presswire
Feb. 24, 2026
EMVision Medical Devices to Present at Australia Investor Day February 26th
Indeterminate
GlobeNewswire
Feb. 24, 2026
Australia Investor Day Hybrid Investor Conference Agenda Announced for February 26th
Indeterminate
GlobeNewswire
Feb. 24, 2026
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
Indeterminate
GlobeNewswire
Feb. 24, 2026
Amaero Announces Intention to Re-Domicile to The United States
Indeterminate
GlobeNewswire
Feb. 24, 2026
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
Indeterminate
GlobeNewswire